Dermatitis, Atopic: all 1,443 studies

Page 4 of 15. Open to participants first (253), then studies with results posted, then the rest; newest registration first within each.

• Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic DermatitisCompletedNCT05186805Phase 2Results posted
• Targeted Investigation of Microbiome EliminationTerminatedNCT05177328Phase 1Results posted
• A Study to Assess Subcutaneous Lirentelimab (AK002) in Atopic DermatitisTerminatedNCT05155085Phase 2Results posted
• A Study of Lebrikizumab in Combination With Topical Corticosteroids in Patients With Atopic Dermatitis (AD) That Are Not Adequately Controlled With or Are Non-eligible for CyclosporineCompletedNCT05149313Phase 3Results posted
• Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic DermatitisCompletedNCT05142774Phase 3Results posted
• Study Testing Response Effect of KY1005 Against Moderate-to-Severe Atopic Dermatitis, The STREAM-AD StudyCompletedNCT05131477Phase 2Results posted
• Ruxolitinib Cream in Participants With Facial and/or Neck Atopic Dermatitis InvolvementCompletedNCT05127421Phase 2Results posted
• A Study Investigating the Effect of EDP1815 in the Treatment of Mild, Moderate and Severe Atopic DermatitisCompletedNCT05121480Phase 2Results posted
• Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic DermatitisCompletedNCT05117060Phase 2Results posted
• Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102)CompletedNCT05032859Phase 3Results posted
• Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic DermatitisCompletedNCT05018806Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of CBP-201 in Moderate to Severe Atopic Dermatitis in ChinaCompletedNCT05017480Phase 2Results posted
• Tapinarof for the Treatment of Atopic Dermatitis in Children and AdultsCompletedNCT05014568Phase 3Results posted
• A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic DermatitisCompletedNCT05014438Phase 2Results posted
• Phase 2a Study of the Safety, Tolerability, and Pharmacokinetics of Topically Administered PRN473 (SAR444727) in Patients With Mild to Moderate Atopic DermatitisCompletedNCT04992546Phase 2Results posted
• A Study of Bermekimab for the Treatment of Adult Participants With Moderate-to-Severe Atopic DermatitisTerminatedNCT04990440Phase 2Results posted
• Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic DermatitisCompletedNCT04975438Phase 1Results posted
• The Incidence of Venous Thromboembolism in Atopic DermatitisCompletedNCT04969653Results posted
• An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.CompletedNCT04922021Phase 2Results posted
• A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3)CompletedNCT04921969Phase 3Results posted
• Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT04921345Phase 2Results posted
• The Purpose of the Study is to Evaluate the Effect of Ruxolitinib Cream on Itch in Participants With Atopic DermatitisCompletedNCT04839380Phase 2Results posted
• A Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis.CompletedNCT04836858Phase 2Results posted
• Dupilumab Effect on Pruritus Neuro-mechanisms in Patients With Atopic DermatitisCompletedNCT04823130Phase 4Results posted
• BROadband vs Narrowband photoTherapy for Eczema Trial Nested in the CACTI CohortTerminatedNCT04818138Not applicableResults posted
• A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic DermatitisCompletedNCT04800315Phase 2Results posted
• A Study of Bermekimab (JNJ-77474462) in the Treatment of Participants With Moderate to Severe Atopic DermatitisTerminatedNCT04791319Phase 2Results posted
• Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-II)CompletedNCT04773600Phase 3Results posted
• A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT04760314Phase 3Results posted
• Study of TER-101 Topical Ointment in Subjects With Atopic DermatitisCompletedNCT04753034Phase 2Results posted
• Dupilumab-PEdiatric Skin Barrier Function and LIpidomics STudy in Patients With Atopic DermatitisCompletedNCT04718870Phase 4Results posted
• To Assess the Efficacy and Safety of SCD-044 in the Treatment of Moderate to Severe Atopic DermatitisCompletedNCT04684485Phase 2Results posted
• Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic DermatitisCompletedNCT04668066Phase 1Results posted
• Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque PsoriasisCompletedNCT04664153Phase 2Results posted
• A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA)CompletedNCT04626297Phase 3Results posted
• Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic DermatitisTerminatedNCT04605094Phase 2Results posted
• Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic DermatitisCompletedNCT04598269Phase 2Results posted
• Tralokinumab in Combination With Topical Corticosteroids in Japanese Subjects With Moderate-to-severe Atopic DermatitisCompletedNCT04587453Phase 3Results posted
• A Study to Assess the Effects of Nemolizumab on Cytochrome P450 Substrates in Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT04562116Phase 2Results posted
• A Study of the Long-Term Safety of Crisaborole Ointment, 2% in Japanese Pediatric and Adult Participants With Mild to Moderate Atopic DermatitisTerminatedNCT04498403Phase 3Results posted
• B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic DermatitisCompletedNCT04490109Phase 2Results posted
• Dupilumab Skin Barrier Function Study in Atopic DermatitisCompletedNCT04447417Phase 4Results posted
• A Study to Assess the Efficacy and Safety of CBP-201 in Adult Subjects With Moderate to Severe Atopic DermatitisCompletedNCT04444752Phase 2Results posted
• Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)CompletedNCT04392154Phase 3Results posted
• A Study to Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With NemolizumabCompletedNCT04365387Phase 2Results posted
• Crisaborole for Chinese and Japanese Subjects (≥2 Years of Age) With Mild to Moderate Atopic DermatitisCompletedNCT04360187Phase 3Results posted
• Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical TherapyCompletedNCT04345367Phase 3Results posted
• Topically Applied AMTX-100 CF for Adult Patients With Mild to Moderate Atopic DermatitisCompletedNCT04313400Phase 1/2Results posted
• Apremilast 30 mg Twice Daily (BID) Combined With DupilumabCompletedNCT04306965Phase 2Results posted
• Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT04250350Phase 3Results posted
• Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis.CompletedNCT04250337Phase 3Results posted
• Tofacitinib for Immune Skin Conditions in Down SyndromeCompletedNCT04246372Phase 2Results posted
• A Study for AR100DP1 in Mild to Moderate Atopic Dermatitis (AD)TerminatedNCT04220411Phase 1/2Results posted
• Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic DermatitisCompletedNCT04212169Phase 2Results posted
• Open-Label Extension Study of Upadacitinib in Adult Participants With Moderate to Severe Atopic DermatitisCompletedNCT04195698Phase 3Results posted
• Skin bioMARkers for Atopic Eczema Therapy EvaluationCompletedNCT04194814Phase 2Results posted
• Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic DermatitisCompletedNCT04178967Phase 3Results posted
• A Phase II Study in Adult Patients With Moderate to Severe Atopic DermatitisCompletedNCT04162899Phase 2Results posted
• A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic DermatitisCompletedNCT04162769Phase 2Results posted
• Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1)CompletedNCT04146363Phase 3Results posted
• Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2)TerminatedNCT04140695Phase 3Results posted
• A Study to Test the Long-term Safety of BI 655130 in Patients With Atopic Eczema Who Took Part in Study 1368-0032TerminatedNCT04086121Phase 2Results posted
• A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic DermatitisCompletedNCT04040192Phase 3Results posted
• SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"CompletedNCT04033367Phase 4Results posted
• A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic DermatitisCompletedNCT04021862Phase 2Results posted
• Efficacy & Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic DermatitisCompletedNCT03989349Phase 3Results posted
• Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic DermatitisCompletedNCT03985943Phase 3Results posted
• Team-Based Connected Health (TCH) to Improve Clinical Outcomes and Access in Atopic DermatitisCompletedNCT03981926Not applicableResults posted
• Long-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic DermatitisCompletedNCT03961529Phase 3Results posted
• Study to Assess Efficacy and Safety of Two Regimens of Crisaborole Ointment 2% in Japanese Participants Aged ≥2 Years With Mild to Moderate Atopic DermatitisCompletedNCT03954158Phase 2Results posted
• A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic DermatitisCompletedNCT03952559Phase 3Results posted
• A Study to Assess the Safety and Efficacy of ZPL389 With TCS/TCI in Atopic Dermatitis PatientsTerminatedNCT03948334Phase 2Results posted
• A Pharmacokinetics and Safety Study of Nemolizumab in Adolescent Participants With Atopic Dermatitis (AD)CompletedNCT03921411Phase 2Results posted
• Safety and Efficacy of ARQ-151 Cream in Adolescents and Adults With Atopic DermatitisCompletedNCT03916081Phase 2Results posted
• Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic DermatitisCompletedNCT03915496Phase 2Results posted
• Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic DermatitisCompletedNCT03912259Phase 3Results posted
• Comparison Trial of OPA-15406 Ointment in Pediatric Patients With Atopic DermatitisCompletedNCT03911401Phase 3Results posted
• Comparison Trial of OPA-15406 Ointment in Adult Patients With Atopic DermatitisSyndromeCompletedNCT03908970Phase 3Results posted
• Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic DermatitisCompletedNCT03903822Phase 2Results posted
• A NOVel Moisturiser for Atopic Dermatitis: Effect on the Skin BarrierCompletedNCT03901144Phase 2Results posted
• A Study to Evaluate the Safety and Tolerability of MOR106 Administered Concomitantly With Topical Corticosteroids, in Adult Participants With Moderate to Severe Atopic DermatitisTerminatedNCT03864627Phase 2Results posted
• Clobetasol Topical Oil for Children With Moderate to Severe Atopic DermatitisTerminatedNCT03847389Phase 1/2Results posted
• A Study of LY3375880 in Adults With Moderate-to-Severe Atopic DermatitisTerminatedNCT03831191Phase 2Results posted
• Study of the Safety, Tolerability and Efficacy of BTX 1204 in Patients With Moderate Atopic DermatitisCompletedNCT03824405Phase 2Results posted
• Trends in the Epidemiology and Treatment of Atopic Dermatitis in the United Kingdom (UK)CompletedNCT03823794Results posted
• A Study in Patients With Atopic Eczema to Test How Effective BI 655130 is and How Well it is ToleratedCompletedNCT03822832Phase 2Results posted
• Efficacy and Safety of Orally Administered DS107 in Adult Patients With Moderate to Severe Atopic DermatitisTerminatedNCT03817190Phase 2Results posted
• A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic DermatitisTerminatedNCT03809663Phase 2Results posted
• JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic DermatitisCompletedNCT03796676Phase 3Results posted
• A Study of B244 Delivered as a Topical Spray to Assess Safety in Pediatric Subjects With Atopic DermatitisCompletedNCT03775434Phase 1Results posted
• Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis - ECZTRA 7CompletedNCT03761537Phase 3Results posted
• An Open-Labeled Exploratory Study to Evaluate Safety and Efficacy of FB825 in Adults With Atopic DermatitisCompletedNCT03758716Phase 2Results posted
• A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic DermatitisCompletedNCT03747575Phase 2Results posted
• TRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic DermatitisCompletedNCT03745651Phase 3Results posted
• Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE AD1) - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic DermatitisCompletedNCT03745638Phase 3Results posted
• Efficacy, Safety, and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to-Severe Atopic DermatitisTerminatedNCT03738423Phase 2Results posted
• A Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic DermatitisCompletedNCT03738397Phase 3Results posted
• Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic DermatitisTerminatedNCT03736967Phase 2Results posted
• A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic DermatitisCompletedNCT03733301Phase 3Results posted
• Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.CompletedNCT03725722Phase 2Results posted

← Dermatitis, Atopic overview